Target intelligence / Profile preview

Beta-1,3-D-glucan synthase

Molecular classification
Enzyme, Glycosyltransferase, GT48 family (fungal and plant; CAZy classification)
01

Overview

Beta-1,3-D-glucan synthase is a multi-subunit enzyme complex and a member of the glycosyltransferase superfamily, primarily responsible for the synthesis of beta-1,3-D-glucan, a critical scaffold component of the fungal cell wall. The main catalytic subunit in many fungi is FKS1, which catalyzes the transfer of glucose from UDP-glucose to elongate the beta-1,3-D-glucan polymer, forming the backbone for cross-linked cell wall structures. The enzyme is embedded in the plasma membrane and its activity is unique to fungi, making it a prime target for antifungal agents such as echinocandins and ibrexafungerp. Loss or inhibition of this enzyme disrupts cell wall integrity, leading to osmotic fragility and cell death. The structure of the enzyme includes a conserved glycosyltransferase domain and multiple transmembrane helices, with the regulatory protein Rho1 playing a role in its activation. Resistance to inhibitors is most commonly associated with mutations in the FKS1 gene[1][2][3][5][6].

Other names
1,3-beta-glucan synthaseβ-1,3-glucan synthaseBeta-1,3-glucan synthase1,3-β-D-glucan synthaseCallose synthaseFKS1 (in yeast; refers to the main catalytic subunit)
02

Mechanism of action

Inhibition of (beta)-1,3-D-glucan synthesis in fungal cell walls, leading to cell lysis and death

03

Biological functions

Fungal cell wall biosynthesisPolysaccharide (1,3-beta-D-glucan) synthesisCell wall integrity maintenance
04

Disease associations

Infection (as an antifungal drug target)
05

Safety considerations

Potential emergence of drug resistance mutations (notably in FKS1 gene)Specificity for fungal enzymes reduces off-target toxicity, but hypersensitivity or liver function abnormalities may occur with drugs
06

Interacting drugs

Caspofungin

3 more in the full profile.

07

Biomarkers

Beta-D-glucan (circulating levels used as a biomarker for invasive fungal infection diagnosis, though not specifically for target engagement monitoring)

Beyond the preview

Go deeper on Beta-1,3-D-glucan synthase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,3-D-glucan synthase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call